You have 9 free searches left this month | for more free features.

Progressive ratio

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autism Trial in Atlanta (Training trials, Progressive Ratio Session, Re-test)

Completed
  • Autism
  • Training trials
  • +3 more
  • Atlanta, Georgia
    Marcus Autism Center
Feb 26, 2021

Opioid Dependence, Obesity Trial in Baltimore (behavioral, procedure, dietary supplement)

Completed
  • Opioid Dependence
  • Obesity
  • Sniffin' Sticks Odor Identification and Hedonic Scale
  • +5 more
  • Baltimore, Maryland
  • +1 more
Dec 14, 2020

Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

Not yet recruiting
  • Glomerulonephritis, IGA
  • Blood collection
  • Urine sample
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Mar 17, 2023

Roux-en-Y Bariatric Surgery Trial in Dublin (Octreotide, Saline)

Completed
  • Roux-en-Y Bariatric Surgery
  • Dublin, Ireland
    University College Dublin Clinical Research Centre
May 20, 2022

Burns, Physiotherapy, Aerobic Exercises Trial in Gaziantep (Control Group, Aerobic Exercises group)

Recruiting
  • Burns
  • +2 more
  • Control Group
  • Aerobic Exercises group
  • Gaziantep, Turkey
    Hasan Kalyoncu University
Aug 22, 2023

Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)

Not yet recruiting
  • Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Nicotinamid riboside
  • Placebo
  • Bergen, Norway
    Haukeland University Hospital
Feb 22, 2023

NSCLC Trial in Guangzhou (TGRX-326)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 18, 2023

Fatigue, Sleep and Quality of Life in Parkinson's Patients

Recruiting
  • Idiopathic Parkinson's Disease
    • Niğde, Turkey
      Nigde Omer Halisdemir University Treaning and Research Hospital
    Jan 18, 2023

    Multiple Sclerosis (MS) Patients

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
      • (no location specified)
      Dec 15, 2022

      Cocaine Use Disorder Trial in Lexington (Suvorexant, Cocaine, Placebo oral capsule)

      Completed
      • Cocaine Use Disorder
      • Lexington, Kentucky
        University of Kentucky
      Dec 7, 2022

      Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Empagliflozin 10 MG
      • Placebo
      • (no location specified)
      Oct 30, 2023

      Progressive Supranuclear Palsy Trial in Seongnam-si, Seoul (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)

      Not yet recruiting
      • Progressive Supranuclear Palsy
      • GV1001 Placebo
      • +2 more
      • Seongnam-si, Korea, Republic of
      • +4 more
      Apr 19, 2023

      Chronic Thromboembolic Pulmonary Hypertension After Pulmonary

      Not yet recruiting
      • Chronic Thromboembolic Pulmonary Hypertension
        • (no location specified)
        Oct 7, 2023

        Behavior and Behavior Mechanisms Trial in United States (Demand Informed Moderator Analysis)

        Recruiting
        • Behavior and Behavior Mechanisms
        • Demand Informed Moderator Analysis
        • Brentwood, Tennessee
        • +9 more
        Nov 20, 2022

        Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

        Active, not recruiting
        • Primary Progressive Multiple Sclerosis
        • Secondary Progressive Multiple Sclerosis
        • ATA188
        • Placebo
        • La Jolla, California
        • +33 more
        Jul 21, 2022

        Shoulder Impingement Syndrome Trial in Rawalpindi (Progressive resistance training, Traditional physical therapy)

        Recruiting
        • Shoulder Impingement Syndrome
        • Progressive resistance training
        • Traditional physical therapy
        • Rawalpindi, Punjab, Pakistan
          Foundation University College of Physical Therapy
        Oct 8, 2023

        Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

        Recruiting
        • Multiple Sclerosis, Secondary Progressive
        • Multiple Sclerosis
        • Cladribine Subcutaneous Injection
        • 0.9% Chloride Injection Sodium
        • Warsaw, Mazowieckie, Poland
          Institute of Psychiatry and Neurology
        Jul 26, 2023

        Male Infertility Due to Hypospermatogenesis Trial in Nanjing (Omega 3 fatty acid, Placebo oral capsule)

        Recruiting
        • Male Infertility Due to Hypospermatogenesis
        • Omega 3 fatty acid
        • Placebo oral capsule
        • Nanjing, Jiangsu, China
          Center for Reproductive Medicine, Jinling Hospital
        Sep 8, 2021

        Electronic Cigarette Use Trial in Richmond (Tobacco product administration and assessment)

        Recruiting
        • Electronic Cigarette Use
        • Tobacco product administration and assessment
        • Richmond, Virginia
          Center for the Study of Tobacco Products
        Dec 5, 2022

        Parkinson Disease, Progressive Supranuclear Palsy Trial in France (7 Tesla MRI)

        Not yet recruiting
        • Parkinson Disease
        • Progressive Supranuclear Palsy
        • 7 Tesla MRI
        • Aix-en-Provence, France
        • +5 more
        Nov 24, 2023

        Heart Failure Trial in Richmond (Anakinra)

        Recruiting
        • Heart Failure
        • Richmond, Virginia
          Virginia Commonwealth University
        Sep 25, 2023

        Neurofibromatosis Type 2 Trial in United States (REC-2282, Placebo)

        Recruiting
        • Neurofibromatosis Type 2
        • Los Angeles, California
        • +11 more
        Aug 5, 2022

        Platelets to Lymphocytes Ratio Sepsis Trial in Tanta (Platelets to lymphocytes ratio and procalcitonin)

        Recruiting
        • Platelets to Lymphocytes Ratio Sepsis
        • Platelets to lymphocytes ratio and procalcitonin
        • Tanta, Egypt
          Tanta university of medicine
        May 28, 2022

        Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

        Not yet recruiting
        • Glioblastoma
        • (no location specified)
        Sep 25, 2023

        Desmoid Tumor Trial in France (Cryoablation, Chemotherapy drug)

        Not yet recruiting
        • Desmoid Tumor
        • Cryoablation
        • Chemotherapy drug
        • Bordeaux, France
        • +12 more
        Oct 6, 2023